Table 3. Sequelae and long-term treatment failure among women with and without baseline Mycoplasma gentalium (MG) genital tract infection.

Outcome	Cervical and/or endometrial Mg+ n (%) n = 88	Cervical and/or endometrial Mg− n (%) n = 498	Adjusted RR* (95% CI)	Endometrial Mg+ n (%) n = 50	Endometrial Mg− n (%) n = 561	Adjusted RR* (95% CI)
Recurrent pelvic inflammatory disease	24 (28.2)	98 (20.8)	1.6 (0.8 to 3.1)	15 (30.6)	111 (20.8)	1.8 (0.8, 3.8)
Infertility	15 (17.4)	95 (19.4)	1.4 (0.6 to 2.9)	11 (22.0)	104 (18.9)	1.1 (0.7 to 4.0)
Chronic pelvic pain	37 (43.5)	198 (41.4)	1.6 (0.9 to 2.9)	21 (42.0)	226 (42.1)	1.3 (0.6 to 2.7)
Pregnancy	53 (61.6)	278 (56.9)	0.8 (0.4 to 1.5)	29 (58.0)	317 (57.6)	0.7 (0.3 to 1.4)
Live birth	34 (50.7)	207 (48.5)	0.7 (0.3 to 1.3)	19 (46.3)	236 (49.3)	0.6 (0.3 to 1.3)

*All models are adjusted for age, race, Neisseria gonorrhoeae and Chlamydia trachomatis. Infertility, pregnancy and live birth models are additionally adjusted for self reported infertility at baseline.